TRIAL DATA
COMMIT Trial Evaluates Chemoimmunotherapy in dMMR Metastatic Colorectal CancerA new analysis examines what the COMMIT trial can and cannot tell us about combining chemotherapy with immunotherapy in patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer. (Journal of Clinical Oncology)